![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HIV-1 Attachment Inhibitor Prodrug BMS-663068 in
Antiretroviral-Experienced Subjects: Week 48 Safety Analysis
|
|
|
Reported by Jules Levin
EACS 2015 Oct 21-14 Barcelona, Spain - 15th European AIDS Conference
1IrsiCaixa Foundation, UAB, UVic-UCC, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain; 2EPIMED GmbH, Berlin, Germany; 3Victor Babes Infectious Diseases Hospital and University of Medicine, Craiova, Romania; 4Ovidius University Clinical Infectious Diseases Hospital, Constanta, Romania; 5OGBUZ Smolensk Centre for Disease Prevention and Control of AIDS and Infectious Diseases, Smolensk, Russia; 6Bristol-Myers Squibb, Wallingford, Connecticut, USA; 7Bristol-Myers Squibb, Princeton, New Jersey, USA.
![EACS1.gif](../images/102615/102615-10/EACS1.gif)
![EACS2.gif](../images/102615/102615-10/EACS2.gif)
![EACS3.gif](../images/102615/102615-10/EACS3.gif)
![EACS4.gif](../images/102615/102615-10/EACS4.gif)
![EACS5.gif](../images/102615/102615-10/EACS5.gif)
![EACS6.gif](../images/102615/102615-10/EACS6.gif)
![EACS7.gif](../images/102615/102615-10/EACS7.gif)
![EACS8.gif](../images/102615/102615-10/EACS8.gif)
![EACS9.gif](../images/102615/102615-10/EACS9.gif)
![EACS10.gif](../images/102615/102615-10/EACS10.gif)
![EACS11.gif](../images/102615/102615-10/EACS11.gif)
![EACS12.gif](../images/102615/102615-10/EACS12.gif)
![EACS13.gif](../images/102615/102615-10/EACS13.gif)
![EACS14.gif](../images/102615/102615-10/EACS14.gif)
![EACS15.gif](../images/102615/102615-10/EACS15.gif)
![EACS16.gif](../images/102615/102615-10/EACS16.gif)
![EACS17.gif](../images/102615/102615-10/EACS17.gif)
![EACS18.gif](../images/102615/102615-10/EACS18.gif)
![EACS19.gif](../images/102615/102615-10/EACS19.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|